Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients with Atypical Carcinoid Tumors

BACKGROUND: Though the use of adjuvant chemotherapy in patients with pathologically node-positive (pN+) atypical carcinoid tumor of the lung is an accepted practice, controversy exists regarding its utilization in node-negative (pN0) patients. Our aim was to determine if a survival advantage exists...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Thorac Surg
Main Authors: Anderson, Kevin L., Mulvihill, Michael S, Speicher, Paul J, Yerokun, Babatunde A., Gulack, Brian C, Nussbaum, Daniel P, Harpole, David H, D’Amico, Thomas A, Berry, Mark F, Hartwig, Matthew G
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5610099/
https://ncbi.nlm.nih.gov/pubmed/28760471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.05.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados